Stock ENDPQ ENDO INTERNATIONAL PLC
Add to a list
To use this feature you must be a member
Log inSign up

News Endo International plc

Equities

ENDPQ

IE00BJ3V9050

Market Closed - OTC Markets
Other stock markets
 03:42:21 2024-04-18 pm EDT 		5-day change 1st Jan Change
0.0006 USD 0.00% Intraday chart for Endo International plc +100.00% +20.00%
Mar. 22 Fourth Amended Joint Reorganization Plan Approved for Endo International plc CI
Mar. 20 Health Care Down on Rate Bias -- Health Care Roundup DJ

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Endo, Inc. Announces Proposed New Senior Secured Credit Facilities
AQ
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS
AQ
Fourth Amended Joint Reorganization Plan Approved for Endo International plc
CI
Health Care Down on Rate Bias -- Health Care Roundup
DJ
News Highlights : Top Company News of the Day - Wednesday at 5 PM ET
DJ
Drugmaker Endo receives US court approval for bankruptcy restructuring
RE
Drugmaker Endo receives US court approval for bankruptcy restructuring, Bloomberg News reports
RE
Fourth Amended Joint Reorganization Plan Filed by Endo International plc
CI
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
PR
North American Morning Briefing : Stock Futures -2-
DJ
Health Care Flat After Trial Setbacks -- Health Care Roundup
DJ
Endo International plc Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Endo International plc Reports Property, Plant and Equipment Impairment Charges for the Three Months Ended December 31, 2023
CI
Endo International plc Provides Earnings Guidance for the Year 2024
CI
Endo International plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
PR
Drugmaker Endo reaches $465 mln bankruptcy settlement with US
RE
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER
PR
Third Amended Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc
CI
Motion for Exclusivity Period Extension Approved For Endo International plc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENDPQ Stock
  4. News Endo International plc